"alt_sample_name"	"unique_patient_ID"	"sample_type"	"histological_type"	"primarysite"	"arrayedsite"	"summarygrade"	"summarystage"	"tumorstage"	"substage"	"grade"	"age_at_initial_pathologic_diagnosis"	"pltx"	"tax"	"neo"	"days_to_tumor_recurrence"	"recurrence_status"	"days_to_death"	"vital_status"	"os_binary"	"relapse_binary"	"site_of_tumor_first_recurrence"	"primary_therapy_outcome_success"	"debulking"	"percent_normal_cells"	"percent_stromal_cells"	"percent_tumor_cells"	"batch"	"flag"	"flag_notes"	"uncurated_author_metadata"
"GSM1238145"	"Ov_Tumor_Ref_Mix vs. CS-OV-001"	NA	"tumor"	"other"	NA	NA	"high"	"late"	3	"c"	3	50	NA	NA	"n"	NA	"recurrence"	213	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-001///geo_accession: GSM1238145///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-001///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 9.8///characteristics_ch2.3: age at surgery: 50.45///characteristics_ch2.4: histology: MMMT///characteristics_ch2.5: Stage: IIIC///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 7///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238145/GSM1238145_US22502615_251209750932_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238146"	"Ov_Tumor_Ref_Mix vs. CS-OV-002"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	3	"c"	3	76	NA	NA	"n"	NA	"recurrence"	791	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-002///geo_accession: GSM1238146///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-002///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 8.5///characteristics_ch2.3: age at surgery: 75.69///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIC///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 26///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238146/GSM1238146_US22502615_251209754104_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238147"	"Ov_Tumor_Ref_Mix vs. CS-OV-003"	NA	"tumor"	"ser"	NA	NA	"low"	"late"	3	"c"	1	40	NA	NA	"n"	NA	NA	3135	"living"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-003///geo_accession: GSM1238147///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-003///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 9.4///characteristics_ch2.3: age at surgery: 39.66///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIC///characteristics_ch2.6: grade: 1///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 103///characteristics_ch2.9: disease status: Unknown///characteristics_ch2.10: patient status: Alive///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238147/GSM1238147_US22502615_251209750994_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238148"	"Ov_Tumor_Ref_Mix vs. CS-OV-004"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	3	"c"	3	69	NA	NA	"n"	NA	"recurrence"	1004	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-004///geo_accession: GSM1238148///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-004///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 9.2///characteristics_ch2.3: age at surgery: 69.33///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIC///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 33///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238148/GSM1238148_US22502615_251209747186_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238149"	"Ov_Tumor_Ref_Mix vs. CS-OV-005"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	3	"b"	3	82	NA	NA	"n"	NA	"recurrence"	1644	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-005///geo_accession: GSM1238149///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-005///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 9.5///characteristics_ch2.3: age at surgery: 82.01///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIB///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 54///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238149/GSM1238149_US22502615_251209749503_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238150"	"Ov_Tumor_Ref_Mix vs. CS-OV-006"	NA	"tumor"	"other"	NA	NA	"high"	"late"	3	"c"	3	59	NA	NA	"n"	NA	"recurrence"	1248	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-006///geo_accession: GSM1238150///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-006///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 7.5///characteristics_ch2.3: age at surgery: 58.56///characteristics_ch2.4: histology: Adenocarcinoma///characteristics_ch2.5: Stage: IIIC///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 41///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238150/GSM1238150_US22502615_251209747514_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238151"	"Ov_Tumor_Ref_Mix vs. CS-OV-007"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	3	"b"	3	69	NA	NA	"n"	NA	"recurrence"	183	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-007///geo_accession: GSM1238151///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-007///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 8.3///characteristics_ch2.3: age at surgery: 69.32///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIB///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 6///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238151/GSM1238151_US22502615_251209754110_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238152"	"Ov_Tumor_Ref_Mix vs. CS-OV-008"	NA	"tumor"	"other"	NA	NA	"high"	"early"	2	"b"	3	64	NA	NA	"n"	NA	"recurrence"	274	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-008///geo_accession: GSM1238152///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-008///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 9.4///characteristics_ch2.3: age at surgery: 63.54///characteristics_ch2.4: histology: MMMT///characteristics_ch2.5: Stage: IIB///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 9///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238152/GSM1238152_US22502615_251209750954_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238153"	"Ov_Tumor_Ref_Mix vs. CS-OV-009"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	3	"c"	3	68	NA	NA	"n"	NA	"recurrence"	670	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-009///geo_accession: GSM1238153///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-009///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 9.2///characteristics_ch2.3: age at surgery: 67.91///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIC///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 22///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238153/GSM1238153_US22502615_251209754145_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238154"	"Ov_Tumor_Ref_Mix vs. CS-OV-010"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	4	NA	3	86	NA	NA	"n"	NA	"recurrence"	274	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-010///geo_accession: GSM1238154///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-010///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 9.3///characteristics_ch2.3: age at surgery: 85.58///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IV///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 9///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238154/GSM1238154_US22502615_251209749837_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238155"	"Ov_Tumor_Ref_Mix vs. CS-OV-011"	NA	"borderline"	"mucinous"	NA	NA	"low"	"early"	1	"a"	0	40	NA	NA	"n"	NA	"norecurrence"	2039	"living"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-011///geo_accession: GSM1238155///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-011///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 8.9///characteristics_ch2.3: age at surgery: 39.50///characteristics_ch2.4: histology: Mucinous///characteristics_ch2.5: Stage: IA///characteristics_ch2.6: grade: 0///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 67///characteristics_ch2.9: disease status: Free///characteristics_ch2.10: patient status: Alive///characteristics_ch2.11: disease state: Borderline ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Borderline_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238155/GSM1238155_US22502615_251209754811_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238156"	"Ov_Tumor_Ref_Mix vs. CS-OV-012"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	3	"c"	3	68	NA	NA	"n"	NA	NA	1278	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-012///geo_accession: GSM1238156///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-012///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 7.9///characteristics_ch2.3: age at surgery: 68.16///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIC///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 42///characteristics_ch2.9: disease status: Unknown///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238156/GSM1238156_US22502615_251209754098_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238157"	"Ov_Tumor_Ref_Mix vs. CS-OV-013"	NA	"healthy"	NA	NA	NA	NA	NA	NA	NA	NA	45	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-013///geo_accession: GSM1238157///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-013///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 9.9///characteristics_ch2.3: age at surgery: 44.95///characteristics_ch2.4: histology: Normal///characteristics_ch2.5: tissue status: Benign///characteristics_ch2.6: disease status: Benign///characteristics_ch2.7: patient status: Benign///characteristics_ch2.8: disease state: Normal ovarian///characteristics_ch2.9: ///characteristics_ch2.10: ///characteristics_ch2.11: ///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Normal_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238157/GSM1238157_US22502615_251209747185_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238158"	"Ov_Tumor_Ref_Mix vs. CS-OV-014"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	3	"c"	3	60	NA	NA	"n"	NA	"recurrence"	2009	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-014///geo_accession: GSM1238158///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-014///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 9///characteristics_ch2.3: age at surgery: 59.66///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIC///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 66///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238158/GSM1238158_US22502615_251209751008_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238159"	"Ov_Tumor_Ref_Mix vs. CS-OV-015"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	3	"c"	3	62	NA	NA	"n"	NA	"recurrence"	2222	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-015///geo_accession: GSM1238159///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-015///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 8.2///characteristics_ch2.3: age at surgery: 62.28///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIC///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 73///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238159/GSM1238159_US22502615_251209754814_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238160"	"Ov_Tumor_Ref_Mix vs. CS-OV-016"	NA	"tumor"	"ser"	NA	NA	NA	NA	NA	NA	NA	91	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-016///geo_accession: GSM1238160///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-016///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 9.2///characteristics_ch2.3: age at surgery: 90.78///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: grade: unknown///characteristics_ch2.6: tissue status: Primary///characteristics_ch2.7: follow up months: Unknown///characteristics_ch2.8: disease status: Unknown///characteristics_ch2.9: patient status: Unknown///characteristics_ch2.10: disease state: Malignant ovarian///characteristics_ch2.11: ///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238160/GSM1238160_US22502615_251209747447_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238161"	"Ov_Tumor_Ref_Mix vs. CS-OV-017"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	4	NA	3	61	NA	NA	"n"	NA	"recurrence"	578	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-017///geo_accession: GSM1238161///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-017///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 10///characteristics_ch2.3: age at surgery: 60.85///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IV///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: tcga id: TCGA-23-1031///characteristics_ch2.9: follow up months: 19///characteristics_ch2.10: disease status: Not Free///characteristics_ch2.11: patient status: Dead///characteristics_ch2.12: disease state: Malignant ovarian///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238161/GSM1238161_US22502615_251209750982_S02_A01.txt.gz///data_row_count: 20173"
"GSM1238162"	"Ov_Tumor_Ref_Mix vs. CS-OV-018"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	3	"c"	3	44	NA	NA	"n"	NA	"recurrence"	1674	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-018///geo_accession: GSM1238162///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-018///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 9.8///characteristics_ch2.3: age at surgery: 43.81///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIC///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: tcga id: TCGA-23-1028///characteristics_ch2.9: follow up months: 55///characteristics_ch2.10: disease status: Not Free///characteristics_ch2.11: patient status: Dead///characteristics_ch2.12: disease state: Malignant ovarian///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238162/GSM1238162_US22502615_251209747422_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238163"	"Ov_Tumor_Ref_Mix vs. CS-OV-019"	NA	"tumor"	"ser"	NA	NA	"high"	"early"	2	"c"	3	46	NA	NA	"n"	NA	"recurrence"	791	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-019///geo_accession: GSM1238163///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-019///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 9.1///characteristics_ch2.3: age at surgery: 45.53///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIC///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 26///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238163/GSM1238163_US22502615_251209747425_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238164"	"Ov_Tumor_Ref_Mix vs. CS-OV-020"	NA	"borderline"	"ser"	NA	NA	NA	"early"	1	"c"	NA	37	NA	NA	"n"	NA	"norecurrence"	2070	"living"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-020///geo_accession: GSM1238164///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-020///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 9.6///characteristics_ch2.3: age at surgery: 37.07///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IC///characteristics_ch2.6: grade: unknown///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 68///characteristics_ch2.9: disease status: Free///characteristics_ch2.10: patient status: Alive///characteristics_ch2.11: disease state: Borderline ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Borderline_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238164/GSM1238164_US22502615_251209749022_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238165"	"Ov_Tumor_Ref_Mix vs. CS-OV-021"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	3	"b"	3	80	NA	NA	"n"	NA	"recurrence"	2222	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-021///geo_accession: GSM1238165///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-021///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 7.8///characteristics_ch2.3: age at surgery: 80.24///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIB///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 73///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238165/GSM1238165_US22502615_251209749840_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238166"	"Ov_Tumor_Ref_Mix vs. CS-OV-022"	NA	"metastatic"	"ser"	NA	NA	"high"	"late"	3	"c"	3	66	NA	NA	"n"	NA	"recurrence"	2313	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-022///geo_accession: GSM1238166///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-022///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 9.1///characteristics_ch2.3: age at surgery: 65.60///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIC///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Recurrence///characteristics_ch2.8: follow up months: 76///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238166/GSM1238166_US22502615_251209749644_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238167"	"Ov_Tumor_Ref_Mix vs. CS-OV-023"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	3	"c"	3	46	NA	NA	"n"	NA	"recurrence"	1735	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-023///geo_accession: GSM1238167///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-023///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 9.7///characteristics_ch2.3: age at surgery: 45.98///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIC///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 57///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238167/GSM1238167_US22502615_251209750936_S02_A01.txt.gz///data_row_count: 20173"
"GSM1238168"	"Ov_Tumor_Ref_Mix vs. CS-OV-024"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	3	"c"	3	63	NA	NA	"n"	NA	"recurrence"	1552	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-024///geo_accession: GSM1238168///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-024///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 8.9///characteristics_ch2.3: age at surgery: 62.98///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIC///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: tcga id: TCGA-23-1109///characteristics_ch2.9: follow up months: 51///characteristics_ch2.10: disease status: Not Free///characteristics_ch2.11: patient status: Dead///characteristics_ch2.12: disease state: Malignant ovarian///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238168/GSM1238168_US22502615_251209754217_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238169"	"Ov_Tumor_Ref_Mix vs. CS-OV-025"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	4	NA	3	53	NA	NA	"n"	NA	"recurrence"	335	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-025///geo_accession: GSM1238169///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-025///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 9.9///characteristics_ch2.3: age at surgery: 52.79///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IV///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 11///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238169/GSM1238169_US22502615_251209750984_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238170"	"Ov_Tumor_Ref_Mix vs. CS-OV-026"	NA	"healthy"	NA	NA	NA	NA	NA	NA	NA	NA	52	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-026///geo_accession: GSM1238170///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-026///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 9.5///characteristics_ch2.3: age at surgery: 52.25///characteristics_ch2.4: histology: Normal///characteristics_ch2.5: tissue status: Benign///characteristics_ch2.6: disease status: Benign///characteristics_ch2.7: patient status: Benign///characteristics_ch2.8: disease state: Normal ovarian///characteristics_ch2.9: ///characteristics_ch2.10: ///characteristics_ch2.11: ///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Normal_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238170/GSM1238170_US22502615_251209747043_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238171"	"Ov_Tumor_Ref_Mix vs. CS-OV-027"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	4	NA	3	57	NA	NA	"n"	NA	"norecurrence"	1491	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-027///geo_accession: GSM1238171///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-027///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 9.1///characteristics_ch2.3: age at surgery: 56.86///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IV///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 49///characteristics_ch2.9: disease status: Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238171/GSM1238171_US22502615_251209749047_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238172"	"Ov_Tumor_Ref_Mix vs. CS-OV-028"	NA	"borderline"	"ser"	NA	NA	"low"	"late"	3	"c"	0	26	NA	NA	"n"	NA	"recurrence"	1796	"deceased"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-028///geo_accession: GSM1238172///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-028///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 8.9///characteristics_ch2.3: age at surgery: 26.44///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIC///characteristics_ch2.6: grade: 0///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 59///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Borderline ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Borderline_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238172/GSM1238172_US22502615_251209749774_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238173"	"Ov_Tumor_Ref_Mix vs. CS-OV-029"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	3	"c"	3	56	NA	NA	"n"	NA	"recurrence"	548	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-029///geo_accession: GSM1238173///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-029///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 9.3///characteristics_ch2.3: age at surgery: 55.66///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIC///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 18///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238173/GSM1238173_US22502615_251209750969_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238174"	"Ov_Tumor_Ref_Mix vs. CS-OV-030"	NA	"tumor"	"ser"	NA	NA	"low"	"late"	3	"c"	2	60	NA	NA	"n"	NA	"recurrence"	335	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-030///geo_accession: GSM1238174///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-030///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 9.7///characteristics_ch2.3: age at surgery: 60.03///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIC///characteristics_ch2.6: grade: 2///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 11///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238174/GSM1238174_US22502615_251209754146_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238175"	"Ov_Tumor_Ref_Mix vs. CS-OV-031"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	4	NA	3	45	NA	NA	"n"	NA	"norecurrence"	3652	"living"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-031///geo_accession: GSM1238175///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-031///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: age at surgery: 45.32///characteristics_ch2.3: histology: Serous///characteristics_ch2.4: Stage: IV///characteristics_ch2.5: grade: 3///characteristics_ch2.6: tissue status: Primary///characteristics_ch2.7: tcga id: TCGA-23-2077///characteristics_ch2.8: follow up months: 120///characteristics_ch2.9: disease status: Free///characteristics_ch2.10: patient status: Alive///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238175/GSM1238175_US22502615_251209750933_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238176"	"Ov_Tumor_Ref_Mix vs. CS-OV-032"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	3	"c"	3	61	NA	NA	"n"	NA	"norecurrence"	1491	"living"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-032///geo_accession: GSM1238176///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-032///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 9.4///characteristics_ch2.3: age at surgery: 60.71///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIC///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 49///characteristics_ch2.9: disease status: Free///characteristics_ch2.10: patient status: Alive///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238176/GSM1238176_US22502615_251209754797_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238177"	"Ov_Tumor_Ref_Mix vs. CS-OV-033"	NA	"healthy"	NA	NA	NA	NA	NA	NA	NA	NA	55	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-033///geo_accession: GSM1238177///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-033///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 9.2///characteristics_ch2.3: age at surgery: 55.26///characteristics_ch2.4: histology: Normal///characteristics_ch2.5: tissue status: Benign///characteristics_ch2.6: disease status: Benign///characteristics_ch2.7: patient status: Benign///characteristics_ch2.8: disease state: Normal ovarian///characteristics_ch2.9: ///characteristics_ch2.10: ///characteristics_ch2.11: ///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Normal_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238177/GSM1238177_US22502615_251209749469_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238178"	"Ov_Tumor_Ref_Mix vs. CS-OV-034"	NA	"tumor"	"mucinous"	NA	NA	"low"	"early"	1	"a"	2	34	NA	NA	"n"	NA	"norecurrence"	6392	"living"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-034///geo_accession: GSM1238178///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-034///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 9.6///characteristics_ch2.3: age at surgery: 34.28///characteristics_ch2.4: histology: Mucinous///characteristics_ch2.5: Stage: IA///characteristics_ch2.6: grade: 2///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 210///characteristics_ch2.9: disease status: Free///characteristics_ch2.10: patient status: Alive///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238178/GSM1238178_US22502615_251209754210_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238179"	"Ov_Tumor_Ref_Mix vs. CS-OV-035"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	3	"a"	3	74	NA	NA	"n"	NA	"recurrence"	1126	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-035///geo_accession: GSM1238179///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-035///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 9.3///characteristics_ch2.3: age at surgery: 74.26///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIA///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 37///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238179/GSM1238179_US22502615_251209747091_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238180"	"Ov_Tumor_Ref_Mix vs. CS-OV-036"	NA	"tumor"	"mucinous"	NA	NA	"high"	"early"	1	"c"	3	47	NA	NA	"n"	NA	"norecurrence"	5357	"living"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-036///geo_accession: GSM1238180///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-036///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 9.3///characteristics_ch2.3: age at surgery: 47.47///characteristics_ch2.4: histology: Mucinous///characteristics_ch2.5: Stage: IC///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 176///characteristics_ch2.9: disease status: Free///characteristics_ch2.10: patient status: Alive///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238180/GSM1238180_US22502615_251209749642_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238181"	"Ov_Tumor_Ref_Mix vs. CS-OV-037"	NA	"metastatic"	"ser"	NA	NA	"high"	"late"	3	"c"	3	78	NA	NA	"n"	NA	"recurrence"	1187	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-037///geo_accession: GSM1238181///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-037///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 8.6///characteristics_ch2.3: age at surgery: 78.02///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIC///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Recurrence///characteristics_ch2.8: follow up months: 39///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238181/GSM1238181_US22502615_251209754165_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238182"	"Ov_Tumor_Ref_Mix vs. CS-OV-038"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	3	"c"	3	81	NA	NA	"n"	NA	"recurrence"	517	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-038///geo_accession: GSM1238182///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-038///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 8.9///characteristics_ch2.3: age at surgery: 80.72///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIC///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 17///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238182/GSM1238182_US22502615_251209754214_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238183"	"Ov_Tumor_Ref_Mix vs. CS-OV-039"	NA	"tumor"	"endo"	NA	NA	"low"	"early"	1	"c"	2	52	NA	NA	"n"	NA	"norecurrence"	6361	"living"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-039///geo_accession: GSM1238183///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-039///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 8///characteristics_ch2.3: age at surgery: 52.40///characteristics_ch2.4: histology: Endometrioid///characteristics_ch2.5: Stage: IC///characteristics_ch2.6: grade: 2///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 209///characteristics_ch2.9: disease status: Free///characteristics_ch2.10: patient status: Alive///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238183/GSM1238183_US22502615_251209754164_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238184"	"Ov_Tumor_Ref_Mix vs. CS-OV-040"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	3	"b"	3	62	NA	NA	"n"	NA	"recurrence"	944	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-040///geo_accession: GSM1238184///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-040///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 9.5///characteristics_ch2.3: age at surgery: 61.69///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIB///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 31///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238184/GSM1238184_US22502615_251209750938_S02_A01.txt.gz///data_row_count: 20173"
"GSM1238185"	"Ov_Tumor_Ref_Mix vs. CS-OV-041"	NA	"healthy"	NA	NA	NA	NA	NA	NA	NA	NA	74	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-041///geo_accession: GSM1238185///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-041///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 8.3///characteristics_ch2.3: age at surgery: 73.50///characteristics_ch2.4: histology: Normal///characteristics_ch2.5: tissue status: Benign///characteristics_ch2.6: disease status: Benign///characteristics_ch2.7: patient status: Benign///characteristics_ch2.8: disease state: Normal ovarian///characteristics_ch2.9: ///characteristics_ch2.10: ///characteristics_ch2.11: ///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Normal_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238185/GSM1238185_US22502615_251209747511_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238186"	"Ov_Tumor_Ref_Mix vs. CS-OV-042"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	3	"c"	3	45	NA	NA	"n"	NA	"norecurrence"	3439	"living"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-042///geo_accession: GSM1238186///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-042///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 9.1///characteristics_ch2.3: age at surgery: 45.10///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIC///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: tcga id: TCGA-23-1118///characteristics_ch2.9: follow up months: 113///characteristics_ch2.10: disease status: Free///characteristics_ch2.11: patient status: Alive///characteristics_ch2.12: disease state: Malignant ovarian///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238186/GSM1238186_US22502615_251209747044_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238187"	"Ov_Tumor_Ref_Mix vs. CS-OV-043"	NA	"healthy"	NA	NA	NA	NA	NA	NA	NA	NA	55	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-043///geo_accession: GSM1238187///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-043///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 9.8///characteristics_ch2.3: age at surgery: 55.27///characteristics_ch2.4: histology: Normal///characteristics_ch2.5: tissue status: Benign///characteristics_ch2.6: disease status: Benign///characteristics_ch2.7: patient status: Benign///characteristics_ch2.8: disease state: Normal ovarian///characteristics_ch2.9: ///characteristics_ch2.10: ///characteristics_ch2.11: ///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Normal_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238187/GSM1238187_US22502615_251209750940_S02_A01.txt.gz///data_row_count: 20173"
"GSM1238188"	"Ov_Tumor_Ref_Mix vs. CS-OV-044"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	3	"c"	3	43	NA	NA	"n"	NA	"recurrence"	791	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-044///geo_accession: GSM1238188///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-044///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 8.5///characteristics_ch2.3: age at surgery: 43.37///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIC///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 26///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238188/GSM1238188_US22502615_251209754234_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238189"	"Ov_Tumor_Ref_Mix vs. CS-OV-045"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	3	"c"	3	72	NA	NA	"n"	NA	"recurrence"	426	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-045///geo_accession: GSM1238189///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-045///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 8.6///characteristics_ch2.3: age at surgery: 72.37///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIC///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 14///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238189/GSM1238189_US22502615_251209749468_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238190"	"Ov_Tumor_Ref_Mix vs. CS-OV-046"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	3	"c"	3	67	NA	NA	"n"	NA	"recurrence"	61	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-046///geo_accession: GSM1238190///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-046///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 9.4///characteristics_ch2.3: age at surgery: 67.44///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIC///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 2///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238190/GSM1238190_US22502615_251209749773_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238191"	"Ov_Tumor_Ref_Mix vs. CS-OV-047"	NA	"borderline"	"ser"	NA	NA	"low"	"early"	1	"a"	0	54	NA	NA	"n"	NA	"norecurrence"	2435	"living"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-047///geo_accession: GSM1238191///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-047///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 9.6///characteristics_ch2.3: age at surgery: 54.39///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IA///characteristics_ch2.6: grade: 0///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 80///characteristics_ch2.9: disease status: Free///characteristics_ch2.10: patient status: Alive///characteristics_ch2.11: disease state: Borderline ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Borderline_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238191/GSM1238191_US22502615_251209749048_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238192"	"Ov_Tumor_Ref_Mix vs. CS-OV-048"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	3	"c"	3	40	NA	NA	"n"	NA	"recurrence"	2739	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-048///geo_accession: GSM1238192///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-048///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 10///characteristics_ch2.3: age at surgery: 39.97///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIC///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 90///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238192/GSM1238192_US22502615_251209754157_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238193"	"Ov_Tumor_Ref_Mix vs. CS-OV-049"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	3	"c"	3	81	NA	NA	"n"	NA	"recurrence"	548	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-049///geo_accession: GSM1238193///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-049///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 9.5///characteristics_ch2.3: age at surgery: 80.67///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIC///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 18///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238193/GSM1238193_US22502615_251209747538_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238194"	"Ov_Tumor_Ref_Mix vs. CS-OV-050"	NA	"tumor"	"endo"	NA	NA	"high"	"late"	3	"c"	3	76	NA	NA	"n"	NA	"recurrence"	1765	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-050///geo_accession: GSM1238194///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-050///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 9///characteristics_ch2.3: age at surgery: 75.58///characteristics_ch2.4: histology: Endometrioid///characteristics_ch2.5: Stage: IIIC///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 58///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238194/GSM1238194_US22502615_251209754775_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238195"	"Ov_Tumor_Ref_Mix vs. CS-OV-051"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	3	"c"	3	58	NA	NA	"n"	NA	"recurrence"	883	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-051///geo_accession: GSM1238195///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-051///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 9.7///characteristics_ch2.3: age at surgery: 57.98///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIC///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 29///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238195/GSM1238195_US22502615_251209747187_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238196"	"Ov_Tumor_Ref_Mix vs. CS-OV-052"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	4	NA	3	42	NA	NA	"n"	NA	"recurrence"	244	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-052///geo_accession: GSM1238196///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-052///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 9.2///characteristics_ch2.3: age at surgery: 41.63///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IV///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 8///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238196/GSM1238196_US22502615_251209750951_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238197"	"Ov_Tumor_Ref_Mix vs. CS-OV-053"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	3	"c"	3	64	NA	NA	"n"	NA	"recurrence"	335	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-053///geo_accession: GSM1238197///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-053///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 10///characteristics_ch2.3: age at surgery: 63.56///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIC///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 11///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238197/GSM1238197_US22502615_251209754150_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238198"	"Ov_Tumor_Ref_Mix vs. CS-OV-054"	NA	"borderline"	"mucinous"	NA	NA	"low"	"early"	1	"a"	0	54	NA	NA	"n"	NA	"norecurrence"	2192	"living"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-054///geo_accession: GSM1238198///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-054///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 7.4///characteristics_ch2.3: age at surgery: 54.26///characteristics_ch2.4: histology: Mucinous///characteristics_ch2.5: Stage: IA///characteristics_ch2.6: grade: 0///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 72///characteristics_ch2.9: disease status: Free///characteristics_ch2.10: patient status: Alive///characteristics_ch2.11: disease state: Borderline ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Borderline_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238198/GSM1238198_US22502615_251209747550_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238199"	"Ov_Tumor_Ref_Mix vs. CS-OV-055"	NA	"metastatic"	"ser"	NA	NA	"high"	"late"	4	NA	3	66	NA	NA	"n"	NA	"recurrence"	4626	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-055///geo_accession: GSM1238199///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-055///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 8.8///characteristics_ch2.3: age at surgery: 66.46///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IV///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Recurrence///characteristics_ch2.8: follow up months: 152///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238199/GSM1238199_US22502615_251209754168_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238200"	"Ov_Tumor_Ref_Mix vs. CS-OV-056"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	3	"c"	3	58	NA	NA	"n"	NA	"recurrence"	457	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-056///geo_accession: GSM1238200///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-056///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 9.8///characteristics_ch2.3: age at surgery: 57.97///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIC///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 15///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238200/GSM1238200_US22502615_251209748613_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238201"	"Ov_Tumor_Ref_Mix vs. CS-OV-057"	NA	"tumor"	"ser"	NA	NA	"low"	"late"	3	"a"	2	53	NA	NA	"n"	NA	NA	6240	"living"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-057///geo_accession: GSM1238201///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-057///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 9.4///characteristics_ch2.3: age at surgery: 53.07///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIA///characteristics_ch2.6: grade: 2///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 205///characteristics_ch2.9: disease status: Unknown///characteristics_ch2.10: patient status: Alive///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238201/GSM1238201_US22502615_251209750953_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238202"	"Ov_Tumor_Ref_Mix vs. CS-OV-058"	NA	"tumor"	"other"	NA	NA	"high"	"early"	1	"c"	3	83	NA	NA	"n"	NA	"recurrence"	30	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-058///geo_accession: GSM1238202///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-058///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 9.4///characteristics_ch2.3: age at surgery: 83.07///characteristics_ch2.4: histology: MMMT///characteristics_ch2.5: Stage: IC///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 1///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238202/GSM1238202_US22502615_251209751001_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238203"	"Ov_Tumor_Ref_Mix vs. CS-OV-059"	NA	"metastatic"	"ser"	NA	NA	"high"	"early"	1	"a"	3	42	NA	NA	"n"	NA	"recurrence"	487	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-059///geo_accession: GSM1238203///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-059///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 9.3///characteristics_ch2.3: age at surgery: 42.17///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IA///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Recurrence///characteristics_ch2.8: follow up months: 16///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238203/GSM1238203_US22502615_251209751002_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238204"	"Ov_Tumor_Ref_Mix vs. CS-OV-060"	NA	"metastatic"	"endo"	NA	NA	"low"	"late"	3	"b"	2	52	NA	NA	"n"	NA	"recurrence"	1704	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-060///geo_accession: GSM1238204///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-060///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 9.6///characteristics_ch2.3: age at surgery: 51.58///characteristics_ch2.4: histology: Endometrioid///characteristics_ch2.5: Stage: IIIB///characteristics_ch2.6: grade: 2///characteristics_ch2.7: tissue status: Recurrence///characteristics_ch2.8: follow up months: 56///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238204/GSM1238204_US22502615_251209754144_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238205"	"Ov_Tumor_Ref_Mix vs. CS-OV-061"	NA	"borderline"	"ser"	NA	NA	"low"	"late"	3	"c"	1	30	NA	NA	"n"	NA	"norecurrence"	2739	"living"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-061///geo_accession: GSM1238205///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-061///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 10///characteristics_ch2.3: age at surgery: 30.32///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIC///characteristics_ch2.6: grade: 1///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 90///characteristics_ch2.9: disease status: Free///characteristics_ch2.10: patient status: Alive///characteristics_ch2.11: disease state: Borderline ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Borderline_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238205/GSM1238205_US22502615_251209750996_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238206"	"Ov_Tumor_Ref_Mix vs. CS-OV-062"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	4	NA	3	49	NA	NA	"n"	NA	"recurrence"	944	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-062///geo_accession: GSM1238206///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-062///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 9.9///characteristics_ch2.3: age at surgery: 48.71///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IV///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: tcga id: TCGA-23-1113///characteristics_ch2.9: follow up months: 31///characteristics_ch2.10: disease status: Not Free///characteristics_ch2.11: patient status: Dead///characteristics_ch2.12: disease state: Malignant ovarian///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238206/GSM1238206_US22502615_251209750995_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238207"	"Ov_Tumor_Ref_Mix vs. CS-OV-063"	NA	"metastatic"	"ser"	NA	NA	"high"	"late"	3	"c"	3	60	NA	NA	"n"	NA	"recurrence"	1431	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-063///geo_accession: GSM1238207///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-063///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 8.6///characteristics_ch2.3: age at surgery: 59.96///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIC///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Recurrence///characteristics_ch2.8: follow up months: 47///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238207/GSM1238207_US22502615_251209749839_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238208"	"Ov_Tumor_Ref_Mix vs. CS-OV-064"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	3	"a"	3	54	NA	NA	"n"	NA	"norecurrence"	1948	"living"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-064///geo_accession: GSM1238208///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-064///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 9.1///characteristics_ch2.3: age at surgery: 54.02///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIC/IA///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 64///characteristics_ch2.9: disease status: Free///characteristics_ch2.10: patient status: Alive///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238208/GSM1238208_US22502615_251209754725_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238209"	"Ov_Tumor_Ref_Mix vs. CS-OV-065"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	4	NA	3	45	NA	NA	"n"	NA	"recurrence"	1522	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-065///geo_accession: GSM1238209///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-065///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 9.9///characteristics_ch2.3: age at surgery: 45.16///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IV///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: tcga id: TCGA-23-2084///characteristics_ch2.9: follow up months: 50///characteristics_ch2.10: disease status: Not Free///characteristics_ch2.11: patient status: Dead///characteristics_ch2.12: disease state: Malignant ovarian///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238209/GSM1238209_US22502615_251209754133_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238210"	"Ov_Tumor_Ref_Mix vs. CS-OV-066"	NA	"borderline"	"ser"	NA	NA	NA	"early"	1	"b"	NA	84	NA	NA	"n"	NA	"norecurrence"	4840	"deceased"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-066///geo_accession: GSM1238210///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-066///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 9.2///characteristics_ch2.3: age at surgery: 83.94///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IB///characteristics_ch2.6: grade: unknown///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 159///characteristics_ch2.9: disease status: Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Borderline ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Borderline_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238210/GSM1238210_US22502615_251209749643_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238211"	"Ov_Tumor_Ref_Mix vs. CS-OV-067"	NA	"borderline"	"ser"	NA	NA	"low"	"early"	1	"b"	1	67	NA	NA	"n"	NA	"norecurrence"	2252	"living"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-067///geo_accession: GSM1238211///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-067///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 7.2///characteristics_ch2.3: age at surgery: 67.48///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IB///characteristics_ch2.6: grade: 1///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 74///characteristics_ch2.9: disease status: Free///characteristics_ch2.10: patient status: Alive///characteristics_ch2.11: disease state: Borderline ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Borderline_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238211/GSM1238211_US22502615_251209754132_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238212"	"Ov_Tumor_Ref_Mix vs. CS-OV-068"	NA	"benign"	NA	NA	NA	NA	NA	NA	NA	NA	64	NA	NA	"n"	NA	"norecurrence"	2648	"living"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-068///geo_accession: GSM1238212///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-068///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 8.9///characteristics_ch2.3: age at surgery: 63.58///characteristics_ch2.4: histology: Benign///characteristics_ch2.5: tissue status: Benign///characteristics_ch2.6: follow up months: 87///characteristics_ch2.7: disease status: Free///characteristics_ch2.8: patient status: Alive///characteristics_ch2.9: disease state: Benign ovarian///characteristics_ch2.10: ///characteristics_ch2.11: ///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Benign_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238212/GSM1238212_US22502615_251209754111_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238213"	"Ov_Tumor_Ref_Mix vs. CS-OV-069"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	3	"c"	3	57	NA	NA	"n"	NA	"norecurrence"	3074	"living"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-069///geo_accession: GSM1238213///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-069///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 9.1///characteristics_ch2.3: age at surgery: 57.43///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIC///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 101///characteristics_ch2.9: disease status: Free///characteristics_ch2.10: patient status: Alive///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238213/GSM1238213_US22502615_251209749502_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238214"	"Ov_Tumor_Ref_Mix vs. CS-OV-070"	NA	"tumor"	"clearcell"	NA	NA	"high"	"early"	1	"a"	3	81	NA	NA	"n"	NA	"recurrence"	2922	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-070///geo_accession: GSM1238214///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-070///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 9.9///characteristics_ch2.3: age at surgery: 80.93///characteristics_ch2.4: histology: Clear Cell///characteristics_ch2.5: Stage: IA///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 96///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238214/GSM1238214_US22502615_251209751009_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238215"	"Ov_Tumor_Ref_Mix vs. CS-OV-071"	NA	"metastatic"	"ser"	NA	NA	"high"	"late"	3	"c"	3	28	NA	NA	"n"	NA	"recurrence"	1309	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-071///geo_accession: GSM1238215///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-071///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 9.4///characteristics_ch2.3: age at surgery: 28.39///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIC///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Recurrence///characteristics_ch2.8: follow up months: 43///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238215/GSM1238215_US22502615_251209747450_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238216"	"Ov_Tumor_Ref_Mix vs. CS-OV-072"	NA	"tumor"	"ser"	NA	NA	"low"	"late"	3	"b"	1	74	NA	NA	"n"	NA	"recurrence"	1096	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-072///geo_accession: GSM1238216///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-072///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 9.7///characteristics_ch2.3: age at surgery: 73.52///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIB///characteristics_ch2.6: grade: 1///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 36///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238216/GSM1238216_US22502615_251209754724_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238217"	"Ov_Tumor_Ref_Mix vs. CS-OV-073"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	3	"c"	3	65	NA	NA	"n"	NA	"recurrence"	2039	"living"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-073///geo_accession: GSM1238217///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-073///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 9.3///characteristics_ch2.3: age at surgery: 65.23///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIC///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: tcga id: TCGA-23-1023///characteristics_ch2.9: follow up months: 67///characteristics_ch2.10: disease status: Not Free///characteristics_ch2.11: patient status: Alive///characteristics_ch2.12: disease state: Malignant ovarian///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238217/GSM1238217_US22502615_251209754782_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238218"	"Ov_Tumor_Ref_Mix vs. CS-OV-074"	NA	"benign"	NA	NA	NA	NA	NA	NA	NA	NA	46	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-074///geo_accession: GSM1238218///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-074///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 9///characteristics_ch2.3: age at surgery: 45.61///characteristics_ch2.4: histology: Benign///characteristics_ch2.5: tissue status: Benign///characteristics_ch2.6: disease status: Benign///characteristics_ch2.7: patient status: Benign///characteristics_ch2.8: disease state: Benign ovarian///characteristics_ch2.9: ///characteristics_ch2.10: ///characteristics_ch2.11: ///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Benign_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238218/GSM1238218_US22502615_251209747078_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238219"	"Ov_Tumor_Ref_Mix vs. CS-OV-075"	NA	"borderline"	"ser"	NA	NA	"low"	"early"	1	"c"	0	72	NA	NA	"n"	NA	NA	2983	"deceased"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-075///geo_accession: GSM1238219///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-075///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 8.9///characteristics_ch2.3: age at surgery: 72.21///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IC///characteristics_ch2.6: grade: 0///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 98///characteristics_ch2.9: disease status: Unknown///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Borderline ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Borderline_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238219/GSM1238219_US22502615_251209754148_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238220"	"Ov_Tumor_Ref_Mix vs. CS-OV-076"	NA	"tumor"	"ser"	NA	NA	"low"	"late"	3	"c"	2	67	NA	NA	"n"	NA	"recurrence"	1126	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-076///geo_accession: GSM1238220///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-076///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 8///characteristics_ch2.3: age at surgery: 67.35///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIC///characteristics_ch2.6: grade: 2///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 37///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238220/GSM1238220_US22502615_251209754237_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238221"	"Ov_Tumor_Ref_Mix vs. CS-OV-077"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	3	"c"	3	48	NA	NA	"n"	NA	"recurrence"	974	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-077///geo_accession: GSM1238221///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-077///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 9.4///characteristics_ch2.3: age at surgery: 48.15///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIC///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: tcga id: TCGA-23-1027///characteristics_ch2.9: follow up months: 32///characteristics_ch2.10: disease status: Not Free///characteristics_ch2.11: patient status: Dead///characteristics_ch2.12: disease state: Malignant ovarian///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238221/GSM1238221_US22502615_251209754776_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238222"	"Ov_Tumor_Ref_Mix vs. CS-OV-078"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	4	NA	3	69	NA	NA	"n"	NA	"recurrence"	365	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-078///geo_accession: GSM1238222///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-078///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 9///characteristics_ch2.3: age at surgery: 68.88///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IV///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 12///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238222/GSM1238222_US22502615_251209747449_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238223"	"Ov_Tumor_Ref_Mix vs. CS-OV-079"	NA	"tumor"	"ser"	NA	NA	"low"	"late"	3	"c"	2	64	NA	NA	"n"	NA	"recurrence"	822	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-079///geo_accession: GSM1238223///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-079///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 9.2///characteristics_ch2.3: age at surgery: 63.50///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIC///characteristics_ch2.6: grade: 2///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 27///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238223/GSM1238223_US22502615_251209754155_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238224"	"Ov_Tumor_Ref_Mix vs. CS-OV-080"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	3	"c"	3	68	NA	NA	"n"	NA	"recurrence"	761	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-080///geo_accession: GSM1238224///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-080///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 8.3///characteristics_ch2.3: age at surgery: 67.53///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIC///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 25///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238224/GSM1238224_US22502615_251209747092_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238225"	"Ov_Tumor_Ref_Mix vs. CS-OV-081"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	3	"c"	3	56	NA	NA	"n"	NA	"recurrence"	974	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-081///geo_accession: GSM1238225///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-081///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 9.8///characteristics_ch2.3: age at surgery: 55.90///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIC///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 32///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238225/GSM1238225_US22502615_251209749836_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238226"	"Ov_Tumor_Ref_Mix vs. CS-OV-082"	NA	"metastatic"	"ser"	NA	NA	"high"	"late"	3	"c"	3	52	NA	NA	"n"	NA	"recurrence"	1096	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-082///geo_accession: GSM1238226///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-082///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 9.4///characteristics_ch2.3: age at surgery: 52.05///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIC///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Recurrence///characteristics_ch2.8: follow up months: 36///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238226/GSM1238226_US22502615_251209750955_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238227"	"Ov_Tumor_Ref_Mix vs. CS-OV-083"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	4	NA	3	86	NA	NA	"n"	NA	"recurrence"	426	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-083///geo_accession: GSM1238227///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-083///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 8.5///characteristics_ch2.3: age at surgery: 85.52///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IV///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 14///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238227/GSM1238227_US22502615_251209754808_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238228"	"Ov_Tumor_Ref_Mix vs. CS-OV-084"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	3	"c"	3	51	NA	NA	"n"	NA	"norecurrence"	6392	"living"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-084///geo_accession: GSM1238228///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-084///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 9.3///characteristics_ch2.3: age at surgery: 51.36///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIC///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 210///characteristics_ch2.9: disease status: Free///characteristics_ch2.10: patient status: Alive///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238228/GSM1238228_US22502615_251209749355_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238229"	"Ov_Tumor_Ref_Mix vs. CS-OV-085"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	3	"c"	3	57	NA	NA	"n"	NA	"recurrence"	1522	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-085///geo_accession: GSM1238229///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-085///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 8.9///characteristics_ch2.3: age at surgery: 56.74///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIC///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 50///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238229/GSM1238229_US22502615_251209754088_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238230"	"Ov_Tumor_Ref_Mix vs. CS-OV-086"	NA	"tumor"	"endo"	NA	NA	"low"	"early"	2	"c"	2	75	NA	NA	"n"	NA	"norecurrence"	2039	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-086///geo_accession: GSM1238230///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-086///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 9.6///characteristics_ch2.3: age at surgery: 75.01///characteristics_ch2.4: histology: Endometrioid///characteristics_ch2.5: Stage: IIC///characteristics_ch2.6: grade: 2///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 67///characteristics_ch2.9: disease status: Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238230/GSM1238230_US22502615_251209754135_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238231"	"Ov_Tumor_Ref_Mix vs. CS-OV-087"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	3	"b"	3	63	NA	NA	"n"	NA	"recurrence"	1552	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-087///geo_accession: GSM1238231///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-087///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 8.3///characteristics_ch2.3: age at surgery: 62.84///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIC/IB///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 51///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238231/GSM1238231_US22502615_251209754787_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238232"	"Ov_Tumor_Ref_Mix vs. CS-OV-088"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	3	"b"	3	45	NA	NA	"n"	NA	"recurrence"	1522	"living"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-088///geo_accession: GSM1238232///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-088///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 8.9///characteristics_ch2.3: age at surgery: 45.02///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIB///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: tcga id: TCGA-23-1026///characteristics_ch2.9: follow up months: 50///characteristics_ch2.10: disease status: Not Free///characteristics_ch2.11: patient status: Alive///characteristics_ch2.12: disease state: Malignant ovarian///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238232/GSM1238232_US22502615_251209754151_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238233"	"Ov_Tumor_Ref_Mix vs. CS-OV-089"	NA	"borderline"	"mucinous"	NA	NA	"low"	"early"	1	"a"	0	43	NA	NA	"n"	NA	"norecurrence"	2405	"living"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-089///geo_accession: GSM1238233///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-089///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 9.9///characteristics_ch2.3: age at surgery: 42.79///characteristics_ch2.4: histology: Mucinous///characteristics_ch2.5: Stage: IA///characteristics_ch2.6: grade: 0///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 79///characteristics_ch2.9: disease status: Free///characteristics_ch2.10: patient status: Alive///characteristics_ch2.11: disease state: Borderline ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Borderline_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238233/GSM1238233_US22502615_251209749024_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238234"	"Ov_Tumor_Ref_Mix vs. CS-OV-090"	NA	"tumor"	"endo"	NA	NA	"high"	"early"	1	"a"	3	64	NA	NA	"n"	NA	"norecurrence"	6422	"living"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-090///geo_accession: GSM1238234///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-090///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 8.9///characteristics_ch2.3: age at surgery: 64.32///characteristics_ch2.4: histology: Endometrioid///characteristics_ch2.5: Stage: IA///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 211///characteristics_ch2.9: disease status: Free///characteristics_ch2.10: patient status: Alive///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238234/GSM1238234_US22502615_251209754235_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238235"	"Ov_Tumor_Ref_Mix vs. CS-OV-091"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	3	"c"	3	65	NA	NA	"n"	NA	"norecurrence"	4261	"living"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-091///geo_accession: GSM1238235///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-091///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 10///characteristics_ch2.3: age at surgery: 64.85///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIC///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: tcga id: TCGA-23-1119///characteristics_ch2.9: follow up months: 140///characteristics_ch2.10: disease status: Free///characteristics_ch2.11: patient status: Alive///characteristics_ch2.12: disease state: Malignant ovarian///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238235/GSM1238235_US22502615_251209750935_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238236"	"Ov_Tumor_Ref_Mix vs. CS-OV-092"	NA	"tumor"	"ser"	NA	NA	"low"	"late"	3	"a"	1	45	NA	NA	"n"	NA	"recurrence"	1035	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-092///geo_accession: GSM1238236///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-092///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 9.6///characteristics_ch2.3: age at surgery: 44.53///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIA///characteristics_ch2.6: grade: 1///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 34///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238236/GSM1238236_US22502615_251209754798_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238237"	"Ov_Tumor_Ref_Mix vs. CS-OV-093"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	3	"c"	3	53	NA	NA	"n"	NA	"recurrence"	1187	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-093///geo_accession: GSM1238237///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-093///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 9.3///characteristics_ch2.3: age at surgery: 53.49///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIC///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: tcga id: TCGA-23-1102///characteristics_ch2.9: follow up months: 39///characteristics_ch2.10: disease status: Not Free///characteristics_ch2.11: patient status: Dead///characteristics_ch2.12: disease state: Malignant ovarian///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238237/GSM1238237_US22502615_251209747093_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238238"	"Ov_Tumor_Ref_Mix vs. CS-OV-094"	NA	"tumor"	"other"	NA	NA	"high"	"early"	2	"a"	3	63	NA	NA	"n"	NA	"norecurrence"	2344	"living"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-094///geo_accession: GSM1238238///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-094///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 8.4///characteristics_ch2.3: age at surgery: 63.21///characteristics_ch2.4: histology: Transitional Cell///characteristics_ch2.5: Stage: IIA///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 77///characteristics_ch2.9: disease status: Free///characteristics_ch2.10: patient status: Alive///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238238/GSM1238238_US22502615_251209754213_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238239"	"Ov_Tumor_Ref_Mix vs. CS-OV-095"	NA	"tumor"	"mucinous"	NA	NA	"high"	"late"	3	"c"	3	68	NA	NA	"n"	NA	"recurrence"	730	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-095///geo_accession: GSM1238239///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-095///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 8.9///characteristics_ch2.3: age at surgery: 68.12///characteristics_ch2.4: histology: Mucinous///characteristics_ch2.5: Stage: IIIC///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 24///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238239/GSM1238239_US22502615_251209754154_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238240"	"Ov_Tumor_Ref_Mix vs. CS-OV-096"	NA	"tumor"	"endo"	NA	NA	"low"	"early"	1	"a"	1	66	NA	NA	"n"	NA	"recurrence"	1735	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-096///geo_accession: GSM1238240///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-096///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 10///characteristics_ch2.3: age at surgery: 66.32///characteristics_ch2.4: histology: Endometrioid///characteristics_ch2.5: Stage: IA///characteristics_ch2.6: grade: 1///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 57///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238240/GSM1238240_US22502615_251209747077_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238241"	"Ov_Tumor_Ref_Mix vs. CS-OV-097"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	3	"c"	3	64	NA	NA	"n"	NA	"recurrence"	578	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-097///geo_accession: GSM1238241///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-097///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 9.4///characteristics_ch2.3: age at surgery: 64.44///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIC///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 19///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238241/GSM1238241_US22502615_251209754166_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238242"	"Ov_Tumor_Ref_Mix vs. CS-OV-098"	NA	"tumor"	"other"	NA	NA	"high"	"late"	3	"c"	3	74	NA	NA	"n"	NA	"recurrence"	517	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-098///geo_accession: GSM1238242///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-098///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 8.1///characteristics_ch2.3: age at surgery: 73.61///characteristics_ch2.4: histology: MMMT///characteristics_ch2.5: Stage: IIIC///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 17///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238242/GSM1238242_US22502615_251209754147_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238243"	"Ov_Tumor_Ref_Mix vs. CS-OV-099"	NA	"tumor"	"ser"	NA	NA	"low"	"late"	3	"c"	2	68	NA	NA	"n"	NA	"recurrence"	426	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-099///geo_accession: GSM1238243///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-099///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 8.7///characteristics_ch2.3: age at surgery: 68.22///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIC///characteristics_ch2.6: grade: 2///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 14///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238243/GSM1238243_US22502615_251209749771_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238244"	"Ov_Tumor_Ref_Mix vs. CS-OV-100"	NA	"tumor"	"mucinous"	NA	NA	"low"	"late"	3	"b"	2	50	NA	NA	"n"	NA	"recurrence"	639	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-100///geo_accession: GSM1238244///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-100///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 8.6///characteristics_ch2.3: age at surgery: 50.11///characteristics_ch2.4: histology: Mucinous///characteristics_ch2.5: Stage: IIIB///characteristics_ch2.6: grade: 2///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 21///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238244/GSM1238244_US22502615_251209754216_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238245"	"Ov_Tumor_Ref_Mix vs. CS-OV-101"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	3	"c"	3	68	NA	NA	"n"	NA	"recurrence"	304	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-101///geo_accession: GSM1238245///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-101///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 9.8///characteristics_ch2.3: age at surgery: 68.41///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIC///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 10///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238245/GSM1238245_US22502615_251209750937_S02_A01.txt.gz///data_row_count: 20173"
"GSM1238246"	"Ov_Tumor_Ref_Mix vs. CS-OV-102"	NA	"borderline"	"ser"	NA	NA	"low"	"early"	1	"b"	0	54	NA	NA	"n"	NA	"norecurrence"	1765	"living"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-102///geo_accession: GSM1238246///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-102///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 8.9///characteristics_ch2.3: age at surgery: 54.29///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IB///characteristics_ch2.6: grade: 0///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 58///characteristics_ch2.9: disease status: Free///characteristics_ch2.10: patient status: Alive///characteristics_ch2.11: disease state: Borderline ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Borderline_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238246/GSM1238246_US22502615_251209754777_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238247"	"Ov_Tumor_Ref_Mix vs. CS-OV-103"	NA	"healthy"	NA	NA	NA	NA	NA	NA	NA	NA	55	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-103///geo_accession: GSM1238247///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-103///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 8.9///characteristics_ch2.3: age at surgery: 54.60///characteristics_ch2.4: histology: Normal///characteristics_ch2.5: tissue status: Benign///characteristics_ch2.6: disease status: Benign///characteristics_ch2.7: patient status: Benign///characteristics_ch2.8: disease state: Normal ovarian///characteristics_ch2.9: ///characteristics_ch2.10: ///characteristics_ch2.11: ///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Normal_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238247/GSM1238247_US22502615_251209754105_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238248"	"Ov_Tumor_Ref_Mix vs. CS-OV-104"	NA	"healthy"	NA	NA	NA	NA	NA	NA	NA	NA	48	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-104///geo_accession: GSM1238248///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-104///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 9.3///characteristics_ch2.3: age at surgery: 48.38///characteristics_ch2.4: histology: Normal///characteristics_ch2.5: tissue status: Benign///characteristics_ch2.6: disease status: Benign///characteristics_ch2.7: patient status: Benign///characteristics_ch2.8: disease state: Normal ovarian///characteristics_ch2.9: ///characteristics_ch2.10: ///characteristics_ch2.11: ///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Normal_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238248/GSM1238248_US22502615_251209749040_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238249"	"Ov_Tumor_Ref_Mix vs. CS-OV-105"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	3	"c"	3	43	NA	NA	"n"	NA	"recurrence"	1004	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-105///geo_accession: GSM1238249///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-105///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 8.1///characteristics_ch2.3: age at surgery: 42.96///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIC///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: tcga id: TCGA-23-1117///characteristics_ch2.9: follow up months: 33///characteristics_ch2.10: disease status: Not Free///characteristics_ch2.11: patient status: Dead///characteristics_ch2.12: disease state: Malignant ovarian///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238249/GSM1238249_US22502615_251209754236_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238250"	"Ov_Tumor_Ref_Mix vs. CS-OV-106"	NA	"metastatic"	"other"	NA	NA	"high"	"early"	2	"b"	3	76	NA	NA	"n"	NA	"recurrence"	578	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-106///geo_accession: GSM1238250///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-106///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 9///characteristics_ch2.3: age at surgery: 76.18///characteristics_ch2.4: histology: MMMT///characteristics_ch2.5: Stage: IIB///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Recurrence///characteristics_ch2.8: follow up months: 19///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238250/GSM1238250_US22502615_251209749641_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238251"	"Ov_Tumor_Ref_Mix vs. CS-OV-107"	NA	"tumor"	"ser"	NA	NA	"low"	"late"	3	"c"	2	59	NA	NA	"n"	NA	"recurrence"	30	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-107///geo_accession: GSM1238251///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-107///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 9.8///characteristics_ch2.3: age at surgery: 59.03///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIC///characteristics_ch2.6: grade: 2///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: tcga id: TCGA-23-1107///characteristics_ch2.9: follow up months: 1///characteristics_ch2.10: disease status: Not Free///characteristics_ch2.11: patient status: Dead///characteristics_ch2.12: disease state: Malignant ovarian///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238251/GSM1238251_US22502615_251209747423_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238252"	"Ov_Tumor_Ref_Mix vs. CS-OV-108"	NA	"tumor"	"clearcell"	NA	NA	"high"	"late"	3	"c"	3	76	NA	NA	"n"	NA	"recurrence"	974	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-108///geo_accession: GSM1238252///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-108///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 9.4///characteristics_ch2.3: age at surgery: 75.55///characteristics_ch2.4: histology: Clear Cell///characteristics_ch2.5: Stage: IIIC///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 32///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238252/GSM1238252_US22502615_251209749046_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238253"	"Ov_Tumor_Ref_Mix vs. CS-OV-109"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	3	"c"	3	70	NA	NA	"n"	NA	"recurrence"	2070	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-109///geo_accession: GSM1238253///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-109///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 9///characteristics_ch2.3: age at surgery: 70.37///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIC///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 68///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238253/GSM1238253_US22502615_251209750999_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238254"	"Ov_Tumor_Ref_Mix vs. CS-OV-110"	NA	"healthy"	NA	NA	NA	NA	NA	NA	NA	NA	51	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-110///geo_accession: GSM1238254///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-110///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 9///characteristics_ch2.3: age at surgery: 51.30///characteristics_ch2.4: histology: Normal///characteristics_ch2.5: tissue status: Benign///characteristics_ch2.6: disease status: Benign///characteristics_ch2.7: patient status: Benign///characteristics_ch2.8: disease state: Normal ovarian///characteristics_ch2.9: ///characteristics_ch2.10: ///characteristics_ch2.11: ///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Normal_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238254/GSM1238254_US22502615_251209749501_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238255"	"Ov_Tumor_Ref_Mix vs. CS-OV-111"	NA	"tumor"	"other"	NA	NA	"high"	"early"	2	"b"	3	55	NA	NA	"n"	NA	"norecurrence"	2526	"living"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-111///geo_accession: GSM1238255///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-111///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 9.2///characteristics_ch2.3: age at surgery: 55.16///characteristics_ch2.4: histology: Transitional Cell///characteristics_ch2.5: Stage: IIB///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 83///characteristics_ch2.9: disease status: Free///characteristics_ch2.10: patient status: Alive///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238255/GSM1238255_US22502615_251209748615_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238256"	"Ov_Tumor_Ref_Mix vs. CS-OV-112"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	3	"c"	3	49	NA	NA	"n"	NA	"recurrence"	700	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-112///geo_accession: GSM1238256///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-112///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 9.4///characteristics_ch2.3: age at surgery: 48.92///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIC///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 23///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238256/GSM1238256_US22502615_251209750993_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238257"	"Ov_Tumor_Ref_Mix vs. CS-OV-113"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	3	"c"	3	70	NA	NA	"n"	NA	"recurrence"	791	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-113///geo_accession: GSM1238257///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-113///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: age at surgery: 69.91///characteristics_ch2.3: histology: Serous///characteristics_ch2.4: Stage: IIIC///characteristics_ch2.5: grade: 3///characteristics_ch2.6: tissue status: Primary///characteristics_ch2.7: follow up months: 26///characteristics_ch2.8: disease status: Not Free///characteristics_ch2.9: patient status: Dead///characteristics_ch2.10: disease state: Malignant ovarian///characteristics_ch2.11: ///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238257/GSM1238257_US22502615_251209751005_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238258"	"Ov_Tumor_Ref_Mix vs. CS-OV-114"	NA	"tumor"	"clearcell"	NA	NA	"high"	"early"	1	"c"	3	58	NA	NA	"n"	NA	"norecurrence"	1491	"living"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-114///geo_accession: GSM1238258///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-114///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 9.3///characteristics_ch2.3: age at surgery: 58.27///characteristics_ch2.4: histology: Clear Cell///characteristics_ch2.5: Stage: IC///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 49///characteristics_ch2.9: disease status: Free///characteristics_ch2.10: patient status: Alive///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238258/GSM1238258_US22502615_251209749037_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238259"	"Ov_Tumor_Ref_Mix vs. CS-OV-115"	NA	"tumor"	"other"	NA	NA	"high"	"early"	2	"c"	3	53	NA	NA	"n"	NA	"norecurrence"	5753	"living"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-115///geo_accession: GSM1238259///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-115///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 8///characteristics_ch2.3: age at surgery: 52.97///characteristics_ch2.4: histology: MMMT///characteristics_ch2.5: Stage: IIC///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 189///characteristics_ch2.9: disease status: Free///characteristics_ch2.10: patient status: Alive///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238259/GSM1238259_US22502615_251209754103_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238260"	"Ov_Tumor_Ref_Mix vs. CS-OV-116"	NA	"metastatic"	"ser"	NA	NA	"high"	"late"	3	"c"	3	43	NA	NA	"n"	NA	"recurrence"	3044	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-116///geo_accession: GSM1238260///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-116///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 9///characteristics_ch2.3: age at surgery: 43.41///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIC///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Recurrence///characteristics_ch2.8: follow up months: 100///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238260/GSM1238260_US22502615_251209747076_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238261"	"Ov_Tumor_Ref_Mix vs. CS-OV-117"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	3	"c"	3	67	NA	NA	"n"	NA	"recurrence"	1035	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-117///geo_accession: GSM1238261///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-117///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 9.2///characteristics_ch2.3: age at surgery: 66.84///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIC///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 34///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238261/GSM1238261_US22502615_251209747448_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238262"	"Ov_Tumor_Ref_Mix vs. CS-OV-118"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	4	NA	3	56	NA	NA	"n"	NA	"recurrence"	974	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-118///geo_accession: GSM1238262///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-118///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 9.3///characteristics_ch2.3: age at surgery: 55.76///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IV///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 32///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238262/GSM1238262_US22502615_251209748612_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238263"	"Ov_Tumor_Ref_Mix vs. CS-OV-119"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	3	"c"	3	40	NA	NA	"n"	NA	"recurrence"	974	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-119///geo_accession: GSM1238263///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-119///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 8.2///characteristics_ch2.3: age at surgery: 40.08///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIC///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 32///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238263/GSM1238263_US22502615_251209754809_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238264"	"Ov_Tumor_Ref_Mix vs. CS-OV-120"	NA	"metastatic"	"ser"	NA	NA	"high"	"late"	3	"c"	3	67	NA	NA	"n"	NA	"recurrence"	365	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-120///geo_accession: GSM1238264///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-120///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 9.1///characteristics_ch2.3: age at surgery: 67.03///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIC///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Recurrence///characteristics_ch2.8: follow up months: 12///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238264/GSM1238264_US22502615_251209750965_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238265"	"Ov_Tumor_Ref_Mix vs. CS-OV-121"	NA	"healthy"	NA	NA	NA	NA	NA	NA	NA	NA	55	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-121///geo_accession: GSM1238265///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-121///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 8///characteristics_ch2.3: age at surgery: 54.59///characteristics_ch2.4: histology: Normal///characteristics_ch2.5: tissue status: Benign///characteristics_ch2.6: disease status: Benign///characteristics_ch2.7: patient status: Benign///characteristics_ch2.8: disease state: Normal ovarian///characteristics_ch2.9: ///characteristics_ch2.10: ///characteristics_ch2.11: ///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Normal_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238265/GSM1238265_US22502615_251209754142_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238266"	"Ov_Tumor_Ref_Mix vs. CS-OV-122"	NA	"healthy"	NA	NA	NA	NA	NA	NA	NA	NA	64	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-122///geo_accession: GSM1238266///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-122///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: age at surgery: 63.87///characteristics_ch2.3: histology: Normal///characteristics_ch2.4: tissue status: Benign///characteristics_ch2.5: disease status: Benign///characteristics_ch2.6: patient status: Benign///characteristics_ch2.7: disease state: Normal ovarian///characteristics_ch2.8: ///characteristics_ch2.9: ///characteristics_ch2.10: ///characteristics_ch2.11: ///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Normal_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238266/GSM1238266_US22502615_251209750966_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238267"	"Ov_Tumor_Ref_Mix vs. CS-OV-123"	NA	"benign"	NA	NA	NA	NA	NA	NA	NA	NA	50	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-123///geo_accession: GSM1238267///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-123///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 9.2///characteristics_ch2.3: age at surgery: 49.74///characteristics_ch2.4: histology: Benign///characteristics_ch2.5: tissue status: Benign///characteristics_ch2.6: disease status: Benign///characteristics_ch2.7: patient status: Benign///characteristics_ch2.8: disease state: Benign ovarian///characteristics_ch2.9: ///characteristics_ch2.10: ///characteristics_ch2.11: ///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Benign_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238267/GSM1238267_US22502615_251209749023_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238268"	"Ov_Tumor_Ref_Mix vs. CS-OV-124"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	3	"b"	3	48	NA	NA	"n"	NA	"recurrence"	1218	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-124///geo_accession: GSM1238268///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-124///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 7.4///characteristics_ch2.3: age at surgery: 47.84///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIB///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 40///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238268/GSM1238268_US22502615_251209754129_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238269"	"Ov_Tumor_Ref_Mix vs. CS-OV-125"	NA	"tumor"	"ser"	NA	NA	"high"	"early"	1	"c"	3	55	NA	NA	"n"	NA	"norecurrence"	3074	"living"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-125///geo_accession: GSM1238269///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-125///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 7.3///characteristics_ch2.3: age at surgery: 55.27///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IC///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 101///characteristics_ch2.9: disease status: Free///characteristics_ch2.10: patient status: Alive///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238269/GSM1238269_US22502615_251209754130_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238270"	"Ov_Tumor_Ref_Mix vs. CS-OV-126"	NA	"tumor"	"ser"	NA	NA	"low"	"late"	3	"c"	2	56	NA	NA	"n"	NA	"recurrence"	1339	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-126///geo_accession: GSM1238270///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-126///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 9.2///characteristics_ch2.3: age at surgery: 55.82///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIC///characteristics_ch2.6: grade: 2///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 44///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238270/GSM1238270_US22502615_251209750983_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238271"	"Ov_Tumor_Ref_Mix vs. CS-OV-127"	NA	"healthy"	NA	NA	NA	NA	NA	NA	NA	NA	51	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-127///geo_accession: GSM1238271///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-127///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 8.7///characteristics_ch2.3: age at surgery: 51.30///characteristics_ch2.4: histology: Normal///characteristics_ch2.5: tissue status: Benign///characteristics_ch2.6: disease status: Benign///characteristics_ch2.7: patient status: Benign///characteristics_ch2.8: disease state: Normal ovarian///characteristics_ch2.9: ///characteristics_ch2.10: ///characteristics_ch2.11: ///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Normal_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238271/GSM1238271_US22502615_251209754106_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238272"	"Ov_Tumor_Ref_Mix vs. CS-OV-128"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	3	"c"	3	73	NA	NA	"n"	NA	"recurrence"	1857	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-128///geo_accession: GSM1238272///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-128///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 8.6///characteristics_ch2.3: age at surgery: 72.57///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIC///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 61///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238272/GSM1238272_US22502615_251209754096_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238273"	"Ov_Tumor_Ref_Mix vs. CS-OV-129"	NA	"metastatic"	"ser"	NA	NA	"low"	"late"	3	NA	1	76	NA	NA	"n"	NA	"recurrence"	30	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-129///geo_accession: GSM1238273///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-129///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 8.9///characteristics_ch2.3: age at surgery: 76.33///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: III///characteristics_ch2.6: grade: 1///characteristics_ch2.7: tissue status: Recurrence///characteristics_ch2.8: follow up months: 1///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238273/GSM1238273_US22502615_251209749470_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238274"	"Ov_Tumor_Ref_Mix vs. CS-OV-130"	NA	"healthy"	NA	NA	NA	NA	NA	NA	NA	NA	48	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-130///geo_accession: GSM1238274///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-130///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 9.7///characteristics_ch2.3: age at surgery: 47.58///characteristics_ch2.4: histology: Normal///characteristics_ch2.5: tissue status: Benign///characteristics_ch2.6: disease status: Benign///characteristics_ch2.7: patient status: Benign///characteristics_ch2.8: disease state: Normal ovarian///characteristics_ch2.9: ///characteristics_ch2.10: ///characteristics_ch2.11: ///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Normal_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238274/GSM1238274_US22502615_251209750981_S02_A01.txt.gz///data_row_count: 20173"
"GSM1238275"	"Ov_Tumor_Ref_Mix vs. CS-OV-131"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	3	"b"	3	62	NA	NA	"n"	NA	"recurrence"	1948	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-131///geo_accession: GSM1238275///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-131///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 8.5///characteristics_ch2.3: age at surgery: 62.41///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIB///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 64///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238275/GSM1238275_US22502615_251209749504_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238276"	"Ov_Tumor_Ref_Mix vs. CS-OV-132"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	3	"b"	3	46	NA	NA	"n"	NA	"recurrence"	2100	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-132///geo_accession: GSM1238276///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-132///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 9.9///characteristics_ch2.3: age at surgery: 45.90///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIB///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 69///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238276/GSM1238276_US22502615_251209751007_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238277"	"Ov_Tumor_Ref_Mix vs. CS-OV-133"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	3	"c"	3	56	NA	NA	"n"	NA	"norecurrence"	3105	"living"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-133///geo_accession: GSM1238277///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-133///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 10///characteristics_ch2.3: age at surgery: 56.31///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIC///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 102///characteristics_ch2.9: disease status: Free///characteristics_ch2.10: patient status: Alive///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238277/GSM1238277_US22502615_251209750985_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238278"	"Ov_Tumor_Ref_Mix vs. CS-OV-134"	NA	"tumor"	"ser"	NA	NA	"low"	"late"	3	"b"	2	54	NA	NA	"n"	NA	"recurrence"	2709	"living"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-134///geo_accession: GSM1238278///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-134///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 10///characteristics_ch2.3: age at surgery: 53.51///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIB///characteristics_ch2.6: grade: 2///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 89///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Alive///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238278/GSM1238278_US22502615_251209748614_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238279"	"Ov_Tumor_Ref_Mix vs. CS-OV-135"	NA	"metastatic"	"ser"	NA	NA	"high"	"late"	3	"c"	3	38	NA	NA	"n"	NA	"recurrence"	3926	"living"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-135///geo_accession: GSM1238279///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-135///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 9.9///characteristics_ch2.3: age at surgery: 38.18///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIC///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Recurrence///characteristics_ch2.8: follow up months: 129///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Alive///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238279/GSM1238279_US22502615_251209747123_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238280"	"Ov_Tumor_Ref_Mix vs. CS-OV-136"	NA	"healthy"	NA	NA	NA	NA	NA	NA	NA	NA	46	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-136///geo_accession: GSM1238280///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-136///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 8.6///characteristics_ch2.3: age at surgery: 45.83///characteristics_ch2.4: histology: Normal///characteristics_ch2.5: tissue status: Benign///characteristics_ch2.6: disease status: Benign///characteristics_ch2.7: patient status: Benign///characteristics_ch2.8: disease state: Normal ovarian///characteristics_ch2.9: ///characteristics_ch2.10: ///characteristics_ch2.11: ///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Normal_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238280/GSM1238280_US22502615_251209754117_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238281"	"Ov_Tumor_Ref_Mix vs. CS-OV-137"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	4	NA	3	73	NA	NA	"n"	NA	"recurrence"	91	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-137///geo_accession: GSM1238281///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-137///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 9.5///characteristics_ch2.3: age at surgery: 73.14///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IV///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: tcga id: TCGA-23-1032///characteristics_ch2.9: follow up months: 3///characteristics_ch2.10: disease status: Not Free///characteristics_ch2.11: patient status: Dead///characteristics_ch2.12: disease state: Malignant ovarian///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238281/GSM1238281_US22502615_251209749050_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238282"	"Ov_Tumor_Ref_Mix vs. CS-OV-138"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	3	"c"	3	56	NA	NA	"n"	NA	"recurrence"	2070	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-138///geo_accession: GSM1238282///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-138///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 7.9///characteristics_ch2.3: age at surgery: 55.88///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIC///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: tcga id: TCGA-23-1114///characteristics_ch2.9: follow up months: 68///characteristics_ch2.10: disease status: Not Free///characteristics_ch2.11: patient status: Dead///characteristics_ch2.12: disease state: Malignant ovarian///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238282/GSM1238282_US22502615_251209754789_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238283"	"Ov_Tumor_Ref_Mix vs. CS-OV-139"	NA	"tumor"	"ser"	NA	NA	"low"	"late"	3	"c"	2	68	NA	NA	"n"	NA	"recurrence"	639	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-139///geo_accession: GSM1238283///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-139///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 9.5///characteristics_ch2.3: age at surgery: 68.16///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIC///characteristics_ch2.6: grade: 2///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 21///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238283/GSM1238283_US22502615_251209751003_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238284"	"Ov_Tumor_Ref_Mix vs. CS-OV-140"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	3	"c"	3	47	NA	NA	"n"	NA	"recurrence"	2283	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-140///geo_accession: GSM1238284///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-140///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 9.5///characteristics_ch2.3: age at surgery: 46.75///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIC///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 75///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238284/GSM1238284_US22502615_251209751000_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238285"	"Ov_Tumor_Ref_Mix vs. CS-OV-141"	NA	"tumor"	"ser"	NA	NA	"high"	"early"	2	"c"	3	49	NA	NA	"n"	NA	"recurrence"	2770	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-141///geo_accession: GSM1238285///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-141///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 9.7///characteristics_ch2.3: age at surgery: 49.14///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIC///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 91///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238285/GSM1238285_US22502615_251209750968_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238286"	"Ov_Tumor_Ref_Mix vs. CS-OV-142"	NA	"benign"	NA	NA	NA	NA	NA	NA	NA	NA	80	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-142///geo_accession: GSM1238286///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-142///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 9.3///characteristics_ch2.3: age at surgery: 79.70///characteristics_ch2.4: histology: Benign///characteristics_ch2.5: tissue status: Benign///characteristics_ch2.6: disease status: Benign///characteristics_ch2.7: patient status: Benign///characteristics_ch2.8: disease state: Benign ovarian///characteristics_ch2.9: ///characteristics_ch2.10: ///characteristics_ch2.11: ///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Benign_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238286/GSM1238286_US22502615_251209747421_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238287"	"Ov_Tumor_Ref_Mix vs. CS-OV-143"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	3	"a"	3	57	NA	NA	"n"	NA	"recurrence"	3744	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-143///geo_accession: GSM1238287///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-143///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 9.8///characteristics_ch2.3: age at surgery: 56.55///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIA///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: tcga id: TCGA-23-1106///characteristics_ch2.9: follow up months: 123///characteristics_ch2.10: disease status: Not Free///characteristics_ch2.11: patient status: Dead///characteristics_ch2.12: disease state: Malignant ovarian///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238287/GSM1238287_US22502615_251209751006_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238288"	"Ov_Tumor_Ref_Mix vs. CS-OV-144"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	3	"c"	3	71	NA	NA	"n"	NA	"norecurrence"	4079	"living"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-144///geo_accession: GSM1238288///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-144///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 9///characteristics_ch2.3: age at surgery: 71.05///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIC///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 134///characteristics_ch2.9: disease status: Free///characteristics_ch2.10: patient status: Alive///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238288/GSM1238288_US22502615_251209750998_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238289"	"Ov_Tumor_Ref_Mix vs. CS-OV-145"	NA	"borderline"	"mucinous"	NA	NA	"low"	"early"	1	"a"	0	35	NA	NA	"n"	NA	"norecurrence"	2739	"living"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-145///geo_accession: GSM1238289///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-145///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 7.7///characteristics_ch2.3: age at surgery: 35.35///characteristics_ch2.4: histology: Mucinous///characteristics_ch2.5: Stage: IA///characteristics_ch2.6: grade: 0///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 90///characteristics_ch2.9: disease status: Free///characteristics_ch2.10: patient status: Alive///characteristics_ch2.11: disease state: Borderline ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Borderline_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238289/GSM1238289_US22502615_251209747548_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238290"	"Ov_Tumor_Ref_Mix vs. CS-OV-146"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	3	"c"	3	50	NA	NA	"n"	NA	"recurrence"	1583	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-146///geo_accession: GSM1238290///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-146///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 10///characteristics_ch2.3: age at surgery: 49.99///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIC///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 52///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238290/GSM1238290_US22502615_251209754209_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238291"	"Ov_Tumor_Ref_Mix vs. CS-OV-147"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	3	"b"	3	56	NA	NA	"n"	NA	"norecurrence"	7001	"living"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-147///geo_accession: GSM1238291///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-147///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 9.6///characteristics_ch2.3: age at surgery: 55.96///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIB///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 230///characteristics_ch2.9: disease status: Free///characteristics_ch2.10: patient status: Alive///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238291/GSM1238291_US22502615_251209747513_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238292"	"Ov_Tumor_Ref_Mix vs. CS-OV-148"	NA	"metastatic"	"ser"	NA	NA	"high"	"early"	2	"b"	3	45	NA	NA	"n"	NA	"recurrence"	2800	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-148///geo_accession: GSM1238292///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-148///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 10///characteristics_ch2.3: age at surgery: 44.97///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIB///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Recurrence///characteristics_ch2.8: follow up months: 92///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238292/GSM1238292_US22502615_251209754113_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238293"	"Ov_Tumor_Ref_Mix vs. CS-OV-149"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	3	"c"	3	63	NA	NA	"n"	NA	"recurrence"	1796	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-149///geo_accession: GSM1238293///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-149///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: age at surgery: 62.98///characteristics_ch2.3: histology: Serous///characteristics_ch2.4: Stage: IIIC///characteristics_ch2.5: grade: 3///characteristics_ch2.6: tissue status: Primary///characteristics_ch2.7: tcga id: TCGA-23-1124///characteristics_ch2.8: follow up months: 59///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238293/GSM1238293_US22502615_251209750992_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238294"	"Ov_Tumor_Ref_Mix vs. CS-OV-150"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	4	NA	3	45	NA	NA	"n"	NA	"recurrence"	1461	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-150///geo_accession: GSM1238294///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-150///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: age at surgery: 45.04///characteristics_ch2.3: histology: Serous///characteristics_ch2.4: Stage: IV///characteristics_ch2.5: grade: 3///characteristics_ch2.6: tissue status: Primary///characteristics_ch2.7: tcga id: TCGA-23-1021///characteristics_ch2.8: follow up months: 48///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238294/GSM1238294_US22502615_251209754252_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238295"	"Ov_Tumor_Ref_Mix vs. CS-OV-151"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	3	"c"	3	73	NA	NA	"n"	NA	"recurrence"	1339	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-151///geo_accession: GSM1238295///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-151///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 9.4///characteristics_ch2.3: age at surgery: 72.53///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIC///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: tcga id: TCGA-23-2074///characteristics_ch2.9: follow up months: 44///characteristics_ch2.10: disease status: Not Free///characteristics_ch2.11: patient status: Dead///characteristics_ch2.12: disease state: Malignant ovarian///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238295/GSM1238295_US22502615_251209747041_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238296"	"Ov_Tumor_Ref_Mix vs. CS-OV-152"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	4	NA	3	59	NA	NA	"n"	NA	"recurrence"	761	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-152///geo_accession: GSM1238296///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-152///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 9.8///characteristics_ch2.3: age at surgery: 58.87///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IV///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: tcga id: TCGA-23-2072///characteristics_ch2.9: follow up months: 25///characteristics_ch2.10: disease status: Not Free///characteristics_ch2.11: patient status: Dead///characteristics_ch2.12: disease state: Malignant ovarian///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238296/GSM1238296_US22502615_251209747188_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238297"	"Ov_Tumor_Ref_Mix vs. CS-OV-153"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	3	"b"	3	55	NA	NA	"n"	NA	"recurrence"	1278	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-153///geo_accession: GSM1238297///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-153///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 8.2///characteristics_ch2.3: age at surgery: 55.03///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIB///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 42///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238297/GSM1238297_US22502615_251209754215_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238298"	"Ov_Tumor_Ref_Mix vs. CS-OV-154"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	3	"c"	3	68	NA	NA	"n"	NA	"recurrence"	1491	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-154///geo_accession: GSM1238298///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-154///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 9.5///characteristics_ch2.3: age at surgery: 67.87///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIC///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: tcga id: TCGA-23-1022///characteristics_ch2.9: follow up months: 49///characteristics_ch2.10: disease status: Not Free///characteristics_ch2.11: patient status: Dead///characteristics_ch2.12: disease state: Malignant ovarian///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238298/GSM1238298_US22502615_251209749082_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238299"	"Ov_Tumor_Ref_Mix vs. CS-OV-155"	NA	"healthy"	NA	NA	NA	NA	NA	NA	NA	NA	44	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-155///geo_accession: GSM1238299///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-155///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: age at surgery: 43.93///characteristics_ch2.3: histology: Normal///characteristics_ch2.4: tissue status: Benign///characteristics_ch2.5: disease status: Benign///characteristics_ch2.6: patient status: Benign///characteristics_ch2.7: disease state: Normal ovarian///characteristics_ch2.8: ///characteristics_ch2.9: ///characteristics_ch2.10: ///characteristics_ch2.11: ///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Normal_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238299/GSM1238299_US22502615_251209747075_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238300"	"Ov_Tumor_Ref_Mix vs. CS-OV-156"	NA	"metastatic"	"ser"	NA	NA	"high"	"late"	4	NA	3	49	NA	NA	"n"	NA	NA	3622	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-156///geo_accession: GSM1238300///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-156///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 8.4///characteristics_ch2.3: age at surgery: 48.62///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IV///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Recurrence///characteristics_ch2.8: follow up months: 119///characteristics_ch2.9: disease status: Unknown///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238300/GSM1238300_US22502615_251209754114_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238301"	"Ov_Tumor_Ref_Mix vs. CS-OV-157"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	3	"c"	3	79	NA	NA	"n"	NA	"recurrence"	1918	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-157///geo_accession: GSM1238301///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-157///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 8.9///characteristics_ch2.3: age at surgery: 79.46///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIC///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 63///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238301/GSM1238301_US22502615_251209754087_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238302"	"Ov_Tumor_Ref_Mix vs. CS-OV-158"	NA	"benign"	NA	NA	NA	NA	NA	NA	NA	NA	47	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-158///geo_accession: GSM1238302///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-158///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 9.1///characteristics_ch2.3: age at surgery: 46.88///characteristics_ch2.4: histology: Benign///characteristics_ch2.5: tissue status: Benign///characteristics_ch2.6: disease status: Benign///characteristics_ch2.7: patient status: Benign///characteristics_ch2.8: disease state: Benign ovarian///characteristics_ch2.9: ///characteristics_ch2.10: ///characteristics_ch2.11: ///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Benign_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238302/GSM1238302_US22502615_251209749025_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238303"	"Ov_Tumor_Ref_Mix vs. CS-OV-159"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	3	"c"	3	64	NA	NA	"n"	NA	"recurrence"	883	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-159///geo_accession: GSM1238303///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-159///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 9.9///characteristics_ch2.3: age at surgery: 64.50///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIC///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 29///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238303/GSM1238303_US22502615_251209750939_S02_A01.txt.gz///data_row_count: 20173"
"GSM1238304"	"Ov_Tumor_Ref_Mix vs. CS-OV-160"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	3	"c"	3	66	NA	NA	"n"	NA	"recurrence"	944	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-160///geo_accession: GSM1238304///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-160///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 8.5///characteristics_ch2.3: age at surgery: 66.35///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIC///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 31///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238304/GSM1238304_US22502615_251209754810_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238305"	"Ov_Tumor_Ref_Mix vs. CS-OV-161"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	3	"c"	3	58	NA	NA	"n"	NA	"norecurrence"	4535	"living"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-161///geo_accession: GSM1238305///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-161///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 8.1///characteristics_ch2.3: age at surgery: 57.97///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIC///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 149///characteristics_ch2.9: disease status: Free///characteristics_ch2.10: patient status: Alive///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238305/GSM1238305_US22502615_251209747512_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238306"	"Ov_Tumor_Ref_Mix vs. CS-OV-162"	NA	"tumor"	"endo"	NA	NA	"high"	"early"	1	"c"	3	46	NA	NA	"n"	NA	"norecurrence"	2344	"living"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-162///geo_accession: GSM1238306///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-162///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 10///characteristics_ch2.3: age at surgery: 45.91///characteristics_ch2.4: histology: Endometrioid///characteristics_ch2.5: Stage: IC///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 77///characteristics_ch2.9: disease status: Free///characteristics_ch2.10: patient status: Alive///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238306/GSM1238306_US22502615_251209749021_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238307"	"Ov_Tumor_Ref_Mix vs. CS-OV-163"	NA	"tumor"	"other"	NA	NA	"high"	"late"	3	"c"	3	65	NA	NA	"n"	NA	"recurrence"	274	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-163///geo_accession: GSM1238307///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-163///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 9.7///characteristics_ch2.3: age at surgery: 65.44///characteristics_ch2.4: histology: MMMT///characteristics_ch2.5: Stage: IIIC///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 9///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238307/GSM1238307_US22502615_251209749354_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238308"	"Ov_Tumor_Ref_Mix vs. CS-OV-164"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	3	"c"	3	54	NA	NA	"n"	NA	"norecurrence"	2709	"living"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-164///geo_accession: GSM1238308///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-164///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 9.7///characteristics_ch2.3: age at surgery: 54.00///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIC///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 89///characteristics_ch2.9: disease status: Free///characteristics_ch2.10: patient status: Alive///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238308/GSM1238308_US22502615_251209749505_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238309"	"Ov_Tumor_Ref_Mix vs. CS-OV-165"	NA	"healthy"	NA	NA	NA	NA	NA	NA	NA	NA	45	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-165///geo_accession: GSM1238309///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-165///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 9.2///characteristics_ch2.3: age at surgery: 45.32///characteristics_ch2.4: histology: Normal///characteristics_ch2.5: tissue status: Benign///characteristics_ch2.6: disease status: Benign///characteristics_ch2.7: patient status: Benign///characteristics_ch2.8: disease state: Normal ovarian///characteristics_ch2.9: ///characteristics_ch2.10: ///characteristics_ch2.11: ///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Normal_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238309/GSM1238309_US22502615_251209754218_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238310"	"Ov_Tumor_Ref_Mix vs. CS-OV-166"	NA	"metastatic"	"other"	NA	NA	"high"	"late"	3	"c"	3	68	NA	NA	"n"	NA	"recurrence"	1278	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-166///geo_accession: GSM1238310///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-166///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 9.1///characteristics_ch2.3: age at surgery: 68.17///characteristics_ch2.4: histology: Adenocarcinoma///characteristics_ch2.5: Stage: IIIC///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Recurrence///characteristics_ch2.8: follow up months: 42///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238310/GSM1238310_US22502615_251209750962_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238311"	"Ov_Tumor_Ref_Mix vs. CS-OV-167"	NA	"tumor"	"mucinous"	NA	NA	"low"	"early"	1	"a"	1	51	NA	NA	"n"	NA	"norecurrence"	4535	"living"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-167///geo_accession: GSM1238311///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-167///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 9.7///characteristics_ch2.3: age at surgery: 51.18///characteristics_ch2.4: histology: Mucinous///characteristics_ch2.5: Stage: IA///characteristics_ch2.6: grade: 1///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 149///characteristics_ch2.9: disease status: Free///characteristics_ch2.10: patient status: Alive///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238311/GSM1238311_US22502615_251209749353_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238312"	"Ov_Tumor_Ref_Mix vs. CS-OV-168"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	3	"c"	3	70	NA	NA	"n"	NA	"recurrence"	2252	"living"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-168///geo_accession: GSM1238312///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-168///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 9.3///characteristics_ch2.3: age at surgery: 70.26///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIC///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 74///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Alive///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238312/GSM1238312_US22502615_251209754799_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238313"	"Ov_Tumor_Ref_Mix vs. CS-OV-169"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	3	"c"	3	59	NA	NA	"n"	NA	"recurrence"	1035	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-169///geo_accession: GSM1238313///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-169///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 9.5///characteristics_ch2.3: age at surgery: 59.01///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIC///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: tcga id: TCGA-23-1123///characteristics_ch2.9: follow up months: 34///characteristics_ch2.10: disease status: Not Free///characteristics_ch2.11: patient status: Dead///characteristics_ch2.12: disease state: Malignant ovarian///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238313/GSM1238313_US22502615_251209747031_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238314"	"Ov_Tumor_Ref_Mix vs. CS-OV-170"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	3	"c"	3	70	NA	NA	"n"	NA	"recurrence"	1431	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-170///geo_accession: GSM1238314///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-170///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 8.7///characteristics_ch2.3: age at surgery: 70.35///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIC///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 47///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238314/GSM1238314_US22502615_251209754778_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238315"	"Ov_Tumor_Ref_Mix vs. CS-OV-171"	NA	"tumor"	"ser"	NA	NA	"high"	"late"	3	"c"	3	51	NA	NA	"n"	NA	"recurrence"	1339	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-171///geo_accession: GSM1238315///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-171///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: YES///characteristics_ch2.2: sample rin: 10///characteristics_ch2.3: age at surgery: 51.05///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IIIC///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Primary///characteristics_ch2.8: follow up months: 44///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238315/GSM1238315_US22502615_251209751010_S01_A01.txt.gz///data_row_count: 20173"
"GSM1238316"	"Ov_Tumor_Ref_Mix vs. CS-OV-172"	NA	"metastatic"	"ser"	NA	NA	"high"	"late"	4	NA	3	63	NA	NA	"n"	NA	"recurrence"	1796	"deceased"	NA	NA	NA	NA	NA	"30-"	"30-"	"70+"	NA	NA	NA	"title: Ov_Tumor_Ref_Mix vs. CS-OV-172///geo_accession: GSM1238316///status: Public on Dec 26 2013///submission_date: Sep 23 2013///last_update_date: Dec 26 2013///type: RNA///channel_count: 2///source_name_ch1: 106 pooled ovarian samples///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian///characteristics_ch1.1: sample type: reference pool///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch1: Cy3///label_protocol_ch1: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch1: 9606///source_name_ch2: CS-OV-172///organism_ch2: Homo sapiens///characteristics_ch2: tissue: ovarian///characteristics_ch2.1: sample included in reference pool: NO///characteristics_ch2.2: sample rin: 8.3///characteristics_ch2.3: age at surgery: 62.80///characteristics_ch2.4: histology: Serous///characteristics_ch2.5: Stage: IV///characteristics_ch2.6: grade: 3///characteristics_ch2.7: tissue status: Recurrence///characteristics_ch2.8: follow up months: 59///characteristics_ch2.9: disease status: Not Free///characteristics_ch2.10: patient status: Dead///characteristics_ch2.11: disease state: Malignant ovarian///characteristics_ch2.12: ///molecule_ch2: total RNA///extract_protocol_ch2: Total RNA was isolated using RNeasy (Qiagen Inc., Valencia, CA),quantitated using a Nanodrop Spectrophotometer (Agilent Technolies, Canta Clara, CA), and purified on RNeasy Mini columns (Qiagen Inc.)///label_ch2: Cy5///label_protocol_ch2: Total  RNA (750ng) was labeled with cyanine 5-CTP or cyanine 3-CTP using the Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies)///taxid_ch2: 9606///hyb_protocol: Slides were incubated for 16-17 hr at 60C and washed using the SSPE method described in the Agilent 60-mer Oligo Microarray Processing Protocol, Version 2.1. Slides were treated with Agilent Stabilization and Drying Solution, a wash was used to protect the dyes from ozone degradation.///scan_protocol: Scanned on an Agilent G2565BA scanner.///description: Malignant_ovarian_sample///data_processing: Agilent Feature Extraction Software (v7.5.1) was used for local background subtraction and Linear/LOWESS normalization. RejectMethod=Interquartile Range, nonuniformity outlier flagging enabled, population outlier flag enabled, ratio error model=hybrid, dye normalization select method = Rank Consistency Filter, no spatial detrend method applied.///data_processing.1: Agilent Feature Extraced data was imported into Rosetta Resolver version 7.1.1  (Rosetta Inpharmatics LLC, Cambridge, MA). Multiple probes with the same sequence code were combined into a single value using the Rosetta Resolver error-weighted averaging method for combining repeated measures.///platform_id: GPL7264///contact_name: Judy,,Dering///contact_email: jdering@mednet.ucla.edu///contact_laboratory: Translational Oncology Research///contact_department: Medicine///contact_institute: UCLA School of Medicine///contact_address: 2825 Santa Monica Blvd. Suite 200///contact_city: Santa Monica///contact_state: CA///contact_zip.postal_code: 90404///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1238nnn/GSM1238316/GSM1238316_US22502615_251209754167_S01_A01.txt.gz///data_row_count: 20173"
